The Biosimilar Contract Manufacturing Market is experiencing robust growth as pharmaceutical and biotechnology companies increasingly outsource the production of biosimilar products to specialized contract manufacturing organizations (CMOs). Biosimilars are highly similar versions of approved biologic medicines that offer comparable safety, efficacy, and quality while providing more...